Deregulation of Hepatic Mek1/2⁻Erk1/2 Signaling Module in Iron Overload Conditions.

Pharmaceuticals (Basel) 2019 May 7;12(2). Epub 2019 May 7.

Institute of Comparative Molecular Endocrinology, University of Ulm, Ulm 89081, Germany.

The liver, through the production of iron hormone hepcidin, controls body iron levels. High liver iron levels and deregulated hepcidin expression are commonly observed in many liver diseases including highly prevalent genetic iron overload disorders. In spite of a number of breakthrough investigations into the signals that control hepcidin expression, little progress has been made towards investigations into intracellular signaling in the liver under excess of iron. This study examined hepatic signaling pathways underlying acquired and genetic iron overload conditions. Our data demonstrate that hepatic iron overload associates with a decline in the activation of mitogen-activated protein kinase (MAPK)/extracellular signal-regulated kinase (Erk) kinase (Mek1/2) pathway by selectively affecting the phosphorylation of Erk1/2. We propose that Mek1/2-Erk1/2 signaling is uncoupled from iron-Bmp-Smad-mediated hepcidin induction and that it may contribute to a number of liver pathologies in addition to toxic effects of iron. We believe that our findings will advance the understanding of cellular signaling events in the liver during iron overload of different etiologies.

Download full-text PDF

Source
http://dx.doi.org/10.3390/ph12020070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631327PMC
May 2019
1 Read

Publication Analysis

Top Keywords

iron overload
20
iron
10
hepcidin expression
8
overload conditions
8
iron levels
8
liver iron
8
genetic iron
8
liver
6
overload
5
signaling
5
hepatic iron
4
demonstrate hepatic
4
decline activation
4
associates decline
4
overload associates
4
data demonstrate
4
signal-regulated kinase
4
kinase erk
4
mapk/extracellular signal-regulated
4
kinase mapk/extracellular
4

Similar Publications